Abstract
Coronary artery bypass surgery and angioplasty provide symptomatic relief in patients with ischemic heart disease, but despite advancement in technique and devices, these methods are not applicable in a subset of patients with angina refractory to medical treatment. Bypass surgery may not be feasible because of lack of suitable conduits, diffuse coronary artery disease or poor distal run-off, and coronary angioplasty is sometimes not applicable due to chronic total occlusion, diffuse disease or extreme tortuosity. Transmyocardial laser revascularization and the stimulation of neoangiogenesis by a variety of growth factors have recently emerged as a new tool in the management of these patients. In the first part of this article, we review laser-induced direct myocardial revascularization, its indications, potential risks, and published clinical trials. The induction of neoangiogenesis using different growth factors or the genes encoding for them will be the subject of the second part of our review. (Ital Heart J 2000; 1 (12): 785-794).
| Original language | English |
|---|---|
| Pages (from-to) | 785-794 |
| Number of pages | 10 |
| Journal | Italian Heart Journal |
| Volume | 1 |
| Issue number | 12 |
| Publication status | Published - 2000 |
Fingerprint
Keywords
- Angiogenesis
- Transmyocardial laser revascularization
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Current perspectives : Surgical and percutaneous myocardial angiogenesis induction part I - Laser revascularization. / Gimelli, G.; Di Mario, C.; Dharmadhikari, A. V.; Montorfano, M.; Anzuini, A.; Vaghetti, M.; Puchala-Borowik, M.; Airoldi, F.; Carlino, M.; Tzifos, V.; Maisano, F.; Alfieri, O.; Colombo, A.
In: Italian Heart Journal, Vol. 1, No. 12, 2000, p. 785-794.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Current perspectives
T2 - Surgical and percutaneous myocardial angiogenesis induction part I - Laser revascularization
AU - Gimelli, G.
AU - Di Mario, C.
AU - Dharmadhikari, A. V.
AU - Montorfano, M.
AU - Anzuini, A.
AU - Vaghetti, M.
AU - Puchala-Borowik, M.
AU - Airoldi, F.
AU - Carlino, M.
AU - Tzifos, V.
AU - Maisano, F.
AU - Alfieri, O.
AU - Colombo, A.
PY - 2000
Y1 - 2000
N2 - Coronary artery bypass surgery and angioplasty provide symptomatic relief in patients with ischemic heart disease, but despite advancement in technique and devices, these methods are not applicable in a subset of patients with angina refractory to medical treatment. Bypass surgery may not be feasible because of lack of suitable conduits, diffuse coronary artery disease or poor distal run-off, and coronary angioplasty is sometimes not applicable due to chronic total occlusion, diffuse disease or extreme tortuosity. Transmyocardial laser revascularization and the stimulation of neoangiogenesis by a variety of growth factors have recently emerged as a new tool in the management of these patients. In the first part of this article, we review laser-induced direct myocardial revascularization, its indications, potential risks, and published clinical trials. The induction of neoangiogenesis using different growth factors or the genes encoding for them will be the subject of the second part of our review. (Ital Heart J 2000; 1 (12): 785-794).
AB - Coronary artery bypass surgery and angioplasty provide symptomatic relief in patients with ischemic heart disease, but despite advancement in technique and devices, these methods are not applicable in a subset of patients with angina refractory to medical treatment. Bypass surgery may not be feasible because of lack of suitable conduits, diffuse coronary artery disease or poor distal run-off, and coronary angioplasty is sometimes not applicable due to chronic total occlusion, diffuse disease or extreme tortuosity. Transmyocardial laser revascularization and the stimulation of neoangiogenesis by a variety of growth factors have recently emerged as a new tool in the management of these patients. In the first part of this article, we review laser-induced direct myocardial revascularization, its indications, potential risks, and published clinical trials. The induction of neoangiogenesis using different growth factors or the genes encoding for them will be the subject of the second part of our review. (Ital Heart J 2000; 1 (12): 785-794).
KW - Angiogenesis
KW - Transmyocardial laser revascularization
UR - http://www.scopus.com/inward/record.url?scp=0034565799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034565799&partnerID=8YFLogxK
M3 - Article
VL - 1
SP - 785
EP - 794
JO - Italian Heart Journal
JF - Italian Heart Journal
SN - 1129-471X
IS - 12
ER -